||5R00CA230205-04 Interpret this number
||Sloan-Kettering Inst Can Research
||Uncovering Roles of Metabolites in Colorectal Cancer Etiology
Metabolic perturbation or reprogramming is considered one of the hallmarks of cancer. Several common
metabolic disorders, such as obesity, type 2 diabetes, and dyslipidemia, have been linked to colorectal cancer
(CRC) risk. With the advances in the techniques of metabolomics, hundreds to thousands of metabolites can
be systematically measured in an agnostic manner. For a well-designed prospective metabolomic study of
cancer, the identification of novel risk-associated biomarkers will shed new lights on the cancer etiology and
related biological pathways. Conventional studies evaluating metabolites are costly and may suffer from biases
commonly encountered in the observational studies. It has been increasingly recognized that genetic factors
play a significant role in determining the levels of many metabolites. Herein, I propose a cost-efficient approach
to systematically evaluate the associations between plasma levels of metabolites and CRC risk. I also
incorporate didactic training on molecular/genetic epidemiology, causal inference, cancer biology and
metabolism, and population genetics in this application to accomplish my research and career goals described
below. The proposed research is composed of four aims. In aim 1, I will build models to predict metabolite
levels using existing metabolomics and high-density genotyping data from a public database and possible data
generated at Vanderbilt. In aim 2, metabolites with satisfactory prediction accuracy and meeting other criteria
will be evaluated in three large-scale CRC consortia with a combined sample size of ~80,900 cases and
115,000 controls to assess the associations of genetically predicted metabolite levels with CRC risk. In
collaboration with other investigators during the R00 phase of this award, I will then conduct a nested case-
control study to confirm up to ten metabolites identified from in silico analysis by direct measurement of these
metabolites using pre-diagnosis plasma collected in three large cohort studies (aim 3). Finally, I will evaluate
the potential mediation effects of metabolites for the associations between lifestyle factors including obesity
(body mass index and waist-hip-ratio), physical activity, red meat intakes, vegetable intakes, healthy eating
index and CRC risk (aim 4). This innovative study will, for the first time, systematically search for novel
metabolite biomarkers for CRC risk using genetic instruments and validate the identified associations by direct
measurement. In addition, this study will expand the understanding of underlying mechanisms causing CRC.
The proposed career development award will help me building advanced knowledge of genetic and molecular
epidemiology, cancer metabolism, and CRC etiology and risk assessment to transition to a successful
A Prospective Investigation of Circulating Metabolome Identifies Potential Biomarkers for Gastric Cancer Risk.
, Cai H.
, Lan Q.
, Cai Q.
, Ji B.T.
, Zheng W.
, Shu X.O.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021 Sep; 30(9), p. 1634-1642.
Investigating the associations of glycemic load and glycemic index with lung cancer risk in the Southern Community Cohort Study.
, Yu D.
, Shu X.O.
, Munro H.M.
, Zheng W.
, Blot W.J.
Cancer causes & control : CCC, 2020 Dec; 31(12), p. 1069-1077.